Researchers aim to determine if rapamycin can be used to treat preclinical dilated cardiomyopathy, the second most-common acquired cardiac disease in dogs.
The easy-to-use, cost-effective tool, which will be offered through the Texas A&M Gastrointestinal Lab, represents a significant development in veterinary medicine.